DJIA 18,096.90 -106.47 -0.58%
NASDAQ 4,967.14 -12.76 -0.26%
S&P 500 2,098.53 -9.25 -0.44%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

67.79 -0.49 (-0.72%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AZN $67.79 -0.72%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.66
Previous Close $68.28
Daily Range $67.22 - $67.98
52-Week Range $61.80 - $82.68
Market Cap $85.6B
P/E Ratio 33.47
Dividend (Yield) $3.80 (4.1%)
Ex-Dividend Date
Dividend Pay Date
02/18/15
03/23/15
Volume 1,323,804
Average Daily Volume 1,930,118
Current FY EPS $4.23

Sector

Healthcare

Industry

Drug Makers

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary Rss Feed

Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That

This year will likely mark Pfizer's fifth consecutive year of revenue declines. But a quick solution to its growth concerns could lie within one (or more) of these three proposed fixes.

Rigel (RIGL) Down on Wider Q4 Loss, Revenues Increase Y/Y - Analyst Blog

European Markets Close Lower As Conflicting Reports Circulate Regarding Third Bailout for Greece

10 Dandy Dividend Healthcare Dogs Hail 14% February Upsides

Billionaire George Soros Just Dumped These 3 Dividend Stocks

Controversial hedge fund tycoon George Soros just sold three top dividend stocks. Should you follow his lead?

5 Stocks With Jaw-Dropping Growth Potential

These five small-cap growth stocks could soar in 2015. Here's why.

A Quick Review Of The Asthma Market

Can Isis Pharmaceuticals (ISIS) Beat Earnings this Season? - Analyst Blog

Nektar Therapeutics Incurs Narrower-than-Expected Q4 Loss - Analyst Blog

Nektar Therapeutics Incurs Narrower-than-Expected Q4 Loss - Analyst Blog

Nektar CEO Howard Robin Walks Along His Own Path

See More AZN News...

AZN's Top Competitors

AZN $67.79 (-0.72%)
Current stock: AZN
JNJ $101.65 (-0.67%)
Current stock: JNJ
NVS $99.04 (-0.02%)
Current stock: NVS
RHHBY $33.15 (-0.91%)
Current stock: RHHBY